Literature DB >> 7784107

Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization.

Jan Persson1, Gudmundur Axelsson, Rolf G Hallin, Lars L Gustafsson.   

Abstract

Allodynia is a well-known component of neuropathic pain resulting from injury to the nervous system. Clinical pain states with allodynia in connection with longstanding superficial wounds have, however, not been reported in the literature. In this case a chronic pain state developed in a previously healthy 17-year-old girl in and around a persistently suppurating appendectomy wound. There was no spontaneous pain but pronounced allodynia in the wound and in the surrounding skin. Quantitative thermal tests showed abnormal thresholds for several sensory modalities confirming abnormal processing of sensory input from the involved area. The pattern of sensory abnormalities evaluated with thermal testing changed transiently and the allodynia diminished during a phentolamine block. Since the pain responded poorly to opioids and ketamine has been reported to reduce allodynia, it was administered in a sub-dissociative bolus dose during wound dressing. The wound was essentially unchanged after treatment for 3 months but the allodynia and sensory aberrations had decreased significantly. We interpret these results as a de-sensitizing effect in the long term of repeated NMDA-receptor blockade by ketamine in a chronic pain state, with indications of central sensitization, partially maintained by sympathetic activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7784107     DOI: 10.1016/0304-3959(94)00139-6

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  9 in total

1.  Neuron-astrocyte signaling network in spinal cord dorsal horn mediates painful neuropathy of type 2 diabetes.

Authors:  Jacqueline R Dauch; Brandon M Yanik; Wilson Hsieh; Sang Su Oh; Hsinlin T Cheng
Journal:  Glia       Date:  2012-05-09       Impact factor: 7.452

Review 2.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

Review 3.  Neuropathic pain in children: Special considerations.

Authors:  Gary A Walco; Robert H Dworkin; Elliot J Krane; Alyssa A LeBel; Rolf-Detlef Treede
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

4.  Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation-induced mechanical hyperalgesia in rats.

Authors:  J M Laird; G S Mason; J Webb; R G Hill; R J Hargreaves
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

Review 5.  N-methyl-D-aspartate- enhanced analgesia.

Authors:  David J Hewitt
Journal:  Curr Pain Headache Rep       Date:  2003-02

6.  Ketamine, as adjuvant analgesics for patients with refractory cancer pain, does affect IL-2/IFN-γ expression of T cells in vitro?: A prospective, randomized, double-blind study.

Authors:  Naibao Zhou; Zhijian Fu; Hao Li; Kaiguo Wang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

7.  Antinociceptive interaction of (±)-CPP and propentofylline in monoarthritic rats.

Authors:  Francisco Morales; Luis Constandil; Teresa Pelissier; Alejandro Hernández; Claudio Laurido
Journal:  Arthritis Res Ther       Date:  2012-08-24       Impact factor: 5.156

8.  Expression of nitric oxide synthase isoforms in the dorsal horn of monoarthritic rats: effects of competitive and uncompetitive N-methyl-D-aspartate antagonists.

Authors:  Claudio Infante; Marcelo Díaz; Alejandro Hernández; Luis Constandil; Teresa Pelissier
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome.

Authors:  Ashraf F Hanna; Bishoy Abraham; Andrew Hanna; Adam J Smith
Journal:  Int Med Case Rep J       Date:  2017-08-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.